Global Alliance For Tb Drug Development Inc

New York, NY
Tax-exempt since Sept. 2000
EIN: 13-4128413

Receive an email when new data is available for this organization.

Type of Nonprofit

Designated as a 501(c)(3) Organizations for any of the following purposes: religious, educational, charitable, scientific, literary, testing for public safety, fostering national or international amateur sports competition (as long as it doesn't provide athletic facilities or equipment), or the prevention of cruelty to children or animals.

Category: Medical Research / Specifically Named Diseases Research (NTEE)

Donations to this organization are tax deductible.

Revenue

$60.2M (2023)

Expenses

$55.4M (2023)

Total Assets

$197M (2023)

Total Liabilities

$25.6M (2023)

Source: Form 990 tax filings from 2011 to 2023

Tax Filings and Audits by Year

Form 990 is an information return that most organizations claiming federal tax-exempt status must file yearly with the IRS. Nonprofit Explorer has IRS digitized Form 990 data for filings processed in 2012 and later. If this organization filed an amended return, it may not be reflected below. Duplicate download links may indicate a resubmission or amendment to this organization's original return. Form 990 data is from the IRS.

Audits are required to be submitted by nonprofit organizations that spend $750,000 or more in federal grant money in a fiscal year. "Single audits" look at the entire organization's finances and compliance, while other audits are program specific. Nonprofit Explorer has PDFs of audits for some nonprofits for fiscal year 2015 and later. Audit data is from the Federal Audit Clearinghouse.

Fiscal Year Ending Dec.
2023

Revenue

$60,240,486

Expenses

$55,378,579

Net Income

$4,861,907

Net Assets

$171,699,550

Notable Sources of Revenue		Percent of Total Revenue
Contributions	$49,796,816	82.7%
Program Services	$0
Investment Income	$8,060,173	13.4%
Bond Proceeds	$0
Royalties	$279,003	0.5%
Rental Property Income	$0
Net Fundraising	$0
Sales of Assets	$122,643	0.2%
Net Inventory Sales	$0
Other Revenue	$1,981,851	3.3%

Notable Expenses		Percent of Total Expenses
Executive Compensation	$4,358,087	7.9%
Professional Fundraising Fees	$0
Other Salaries and Wages	$9,825,990	17.7%

Assets/Debt
Total Assets	$197,319,541
Total Liabilities	$25,619,991
Net Assets	$171,699,550

Compensation

Key Employees and Officers	Compensation	Related	Other
Dr Melvin Spigelman (President/Ceo)	$921,007	$0	$107,776
Dr Eugene Sun (Sr. Vp, Research & Dev't)	$562,265	$0	$86,040
Dr Nader Fotouhi (Sr. Vp, Chief Scientific Off.)	$545,570	$0	$114,466
Maria Beumont (Vp, Chief Medical Officer)	$483,078	$0	$81,608
Colleen Pero (Secretary/Cao)	$457,040	$0	$68,861
Robert Lorette (Sr. Vp, Business Development)	$437,313	$0	$83,939
Kathleen Schostack (Sr. Vp, Prog. & Alliance Mgmt)	$419,997	$0	$82,950
Salah Foraida (Sr. Director, Medical Affairs)	$418,194	$0	$50,829
Angela Vanderploeg (Treasurer/Cfo)	$411,013	$0	$100,307
Sandeep Juneja (Sr. Vp, Market Access)	$406,262	$0	$99,678
Rajneesh Taneja (Vp, Pharmaceutical Prod. Dev't)	$360,974	$0	$77,744
Pietro Turilli (Sr.Vp, External Affairs)	$327,992	$0	$91,064
David Norton (Chair)	$0	$0	$0
Ariel Pablos Mendez (Vice Chair)	$0	$0	$0
Eric Goosby (Director)	$0	$0	$0
Rasha Hibri (Director)	$0	$0	$0
Sundar Kodiyalam (Director)	$0	$0	$0
Mario Raviglione (Director)	$0	$0	$0
Kim Schwartz (Director)	$0	$0	$0
Mitchell Warren (Director)	$0	$0	$0
Ratan Watal (Director Eff. 1/1/2023)	$0	$0	$0

+ View more people

990

Filed on Oct. 3, 2024

Primary tax return for a nonprofit’s activities, finances, and governance

View Filing

Schedules ▼

XML

Audit

Audit for an entity that spends $750,000+ in federal grant money in a fiscal year

PDF

Fiscal Year Ending Dec.
2022

Revenue

$56,212,963

Expenses

$55,785,890

Net Income

$427,073

Net Assets

$165,180,519

Notable Sources of Revenue		Percent of Total Revenue
Contributions	$52,646,326	93.7%
Program Services	$0
Investment Income	$2,653,344	4.7%
Bond Proceeds	$0
Royalties	$33,423	0.1%
Rental Property Income	$0
Net Fundraising	$0
Sales of Assets	-$21,446
Net Inventory Sales	$0
Other Revenue	$901,316	1.6%

Notable Expenses		Percent of Total Expenses
Executive Compensation	$3,962,233	7.1%
Professional Fundraising Fees	$0
Other Salaries and Wages	$9,281,300	16.6%

Assets/Debt
Total Assets	$176,686,879
Total Liabilities	$11,506,360
Net Assets	$165,180,519

Compensation

Key Employees and Officers	Compensation	Related	Other
Dr Melvin Spigelman (President/Ceo)	$908,988	$0	$100,869
Dr Eugene Sun (Sr. Vp, Research & Dev't)	$549,342	$0	$86,124
Dr Nader Fotouhi (Chief Scientific Officer)	$533,749	$0	$108,269
Colleen Pero (Secretary/Cao)	$445,698	$0	$66,876
Robert Lorette (Sr. Vp, Business Development)	$426,569	$0	$81,180
Kathleen Schostack (Sr. Vp, Prog. & Alliance Mgmt)	$416,684	$0	$79,826
Salah Foraida (Sr. Director, Medical Affairs)	$408,334	$0	$49,138
Angela Vanderploeg (Treasurer/Cfo)	$402,531	$0	$96,660
Sandeep Juneja (Sr. Vp, Market Access)	$397,339	$0	$96,045
Dr Paul Bruinenberg (Sr. Medical Officer)	$393,693	$0	$79,082
Maria Beumont (Vp, Chief Medical Officer)	$380,489	$0	$73,336
Pietro Turilli (Sr.Vp, Ext Aff(as Of 06/01/22))	$161,060	$0	$48,242
Dr Bruce Carter (Chairman)	$0	$0	$0
Dr Mario Raviglione (Vice Chair)	$0	$0	$0
Eric Goosby (Director)	$0	$0	$0
Jane Griffiths (Director)	$0	$0	$0
Rasha Hibri (Director (As Of 09/01/22))	$0	$0	$0
Sundar Kodiyalam (Director)	$0	$0	$0
David Norton (Director)	$0	$0	$0
Ariel Pablos Mendez (Director)	$0	$0	$0
Sangita Reddy (Director (Thru 05/15/22))	$0	$0	$0
Kim Schwartz (Director (As Of 09/01/22))	$0	$0	$0
Shalini Sharp (Director)	$0	$0	$0
Mitchell Warren (Director)	$0	$0	$0

+ View more people

990

Filed on Nov. 1, 2023

Primary tax return for a nonprofit’s activities, finances, and governance

View Filing

Schedules ▼

PDF XML

Audit

Audit for an entity that spends $750,000+ in federal grant money in a fiscal year

PDF

Fiscal Year Ending Dec.
2021

Revenue

$58,653,379

Expenses

$57,430,605

Net Income

$1,222,774

Net Assets

$165,640,573

Notable Sources of Revenue		Percent of Total Revenue
Contributions	$58,183,286	99.2%
Program Services	$0
Investment Income	$63,272	0.1%
Bond Proceeds	$0
Royalties	$14,605	0.0%
Rental Property Income	$0
Net Fundraising	$0
Sales of Assets	$0
Net Inventory Sales	$0
Other Revenue	$392,216	0.7%

Notable Expenses		Percent of Total Expenses
Executive Compensation	$3,218,688	5.6%
Professional Fundraising Fees	$0
Other Salaries and Wages	$9,595,658	16.7%

Assets/Debt
Total Assets	$187,560,796
Total Liabilities	$21,920,223
Net Assets	$165,640,573

Compensation

Key Employees and Officers	Compensation	Related	Other
Dr Melvin Spigelman (President/Ceo)	$891,812	$0	$96,093
Dr Eugene Sun (Sr. Vp, R&D)	$534,319	$0	$82,707
Dr Nader Fotouhi (Chief Scientific Officer)	$513,209	$0	$104,826
Colleen Pero (Secretary/Cao)	$440,018	$0	$65,089
Robert Lorette (Sr. Vp, Business Development)	$407,543	$0	$77,617
Angela Vanderploeg (Treasurer/Cfo)	$397,277	$0	$93,337
Sandeep Juneja (Sr. Vp, Market Access)	$390,293	$0	$92,750
Dr Paul Bruinenberg (Sr. Medical Officer)	$385,344	$0	$76,392
Kathleen Schostack (Sr. Vp, Prog. & Alliance Mgmt)	$360,401	$0	$73,093
Rajneesh Taneja (Vp, Pharmaceutical Product Dev)	$346,224	$0	$72,708
Dr Bruce Carter (Chairman)	$0	$0	$0
Dr Mario Raviglione (Vice Chair)	$0	$0	$0
Eric Goosby (Director (As Of 06/01/21))	$0	$0	$0
Jane Griffiths (Director)	$0	$0	$0
Sundar Kodiyalam (Director (As Of 06/01/21))	$0	$0	$0
David Norton (Director (As Of 06/01/21))	$0	$0	$0
Ariel Pablos Mendez (Director)	$0	$0	$0
Nancy Miller Rich (Director (Until 12/31/2021))	$0	$0	$0
Sangita Reddy (Director (As Of 09/01/21))	$0	$0	$0
Shalini Sharp (Director)	$0	$0	$0
Mitchell Warren (Director)	$0	$0	$0

+ View more people

990

Filed on Oct. 19, 2022

Primary tax return for a nonprofit’s activities, finances, and governance

View Filing

Schedules ▼

XML

Audit

Audit for an entity that spends $750,000+ in federal grant money in a fiscal year

PDF

Fiscal Year Ending Dec.
2020

Revenue

$61,267,452

Expenses

$61,720,389

Net Income

-$452,937

Net Assets

$164,457,926

Notable Sources of Revenue		Percent of Total Revenue
Contributions	$60,247,338	98.3%
Program Services	$0
Investment Income	$952,541	1.6%
Bond Proceeds	$0
Royalties	$7,585	0.0%
Rental Property Income	$0
Net Fundraising	$0
Sales of Assets	$0
Net Inventory Sales	$0
Other Revenue	$59,988	0.1%

Notable Expenses		Percent of Total Expenses
Executive Compensation	$3,746,893	6.1%
Professional Fundraising Fees	$0
Other Salaries and Wages	$8,288,728	13.4%

Assets/Debt
Total Assets	$191,155,661
Total Liabilities	$26,697,735
Net Assets	$164,457,926

Compensation

Key Employees and Officers	Compensation	Related	Other
Dr Melvin Spigelman (President/Ceo)	$963,760	$0	$93,329
Dr Nader Fotouhi (Chief Scientific Officer)	$550,024	$0	$103,022
Dr Daniel Everitt (Sr. Medical Officer & Vp)	$488,901	$0	$90,370
Dr Eugene Sun (Senior Vp, R&D)	$487,550	$0	$75,913
Colleen Pero (Secretary/Cao)	$455,010	$0	$60,712
Robert Lorette (Sr. Vp, Business Development)	$435,171	$0	$78,989
Angela Vanderploeg (Treasurer/Cfo)	$412,395	$0	$90,282
Sandeep Juneja (Senior Vp, Market Access)	$409,849	$0	$89,517
Dr Paul Bruinenberg (Sr. Medical Officer)	$394,093	$0	$74,377
Willo Brock (Senior Vp, External Affairs)	$381,828	$0	$73,069
Kathleen Schostack (Vp, Program & Alliance Mgmt)	$376,126	$0	$71,702
Dr Bruce Carter (Chairman)	$0	$0	$0
Dr Mario Raviglione (Vice Chair)	$0	$0	$0
Jane Griffiths (Director, As Of 1/1/20)	$0	$0	$0
Jan Landberg (Director)	$0	$0	$0
Ariel Pablos Mendez (Director)	$0	$0	$0
Nancy Miller Rich (Director)	$0	$0	$0
Shalini Sharp (Director)	$0	$0	$0
Mitchell Warren (Director)	$0	$0	$0

+ View more people

990

Filed on Oct. 14, 2021

Primary tax return for a nonprofit’s activities, finances, and governance

View Filing

Schedules ▼

XML

Audit

Audit for an entity that spends $750,000+ in federal grant money in a fiscal year

PDF

Fiscal Year Ending Dec.
2019

Revenue

$174,873,899

Expenses

$69,535,079

Net Income

$105,338,820

Net Assets

$164,687,790

Notable Sources of Revenue		Percent of Total Revenue
Contributions	$68,288,037	39.0%
Program Services	$0
Investment Income	$1,399,584	0.8%
Bond Proceeds	$0
Royalties	$0
Rental Property Income	$0
Net Fundraising	$0
Sales of Assets	$105,000,000	60.0%
Net Inventory Sales	$0
Other Revenue	$186,278	0.1%

Notable Expenses		Percent of Total Expenses
Executive Compensation	$3,378,011	4.9%
Professional Fundraising Fees	$0
Other Salaries and Wages	$8,795,648	12.6%

Assets/Debt
Total Assets	$189,418,881
Total Liabilities	$24,731,091
Net Assets	$164,687,790

Compensation

Key Employees and Officers	Compensation	Related	Other
Dr Melvin Spigelman (President/Ceo)	$859,558	$0	$81,162
Dr Nader Fotouhi (Chief Scientific Officer)	$501,422	$0	$80,454
Colleen Pero (Secretary/Cao)	$416,403	$0	$45,844
Dr Daniel Everitt (Sr. Medical Officer & Vp)	$415,406	$0	$60,664
Robert Lorette (Sr. Vp, Business Development)	$394,347	$0	$59,120
Dr Paul Bruinenberg (Sr. Medical Officer)	$365,125	$0	$57,730
Willo Brock (Senior Vp, External Affairs)	$345,925	$0	$54,949
Dr Kathleen Schostack (Vp, Program & Alliance Mgmt.)	$342,225	$0	$58,177
Sandeep Juneja (Senior Vp, Market Access)	$339,463	$0	$69,738
Angela Vanderploeg (Treasurer/Cfo)	$324,562	$0	$68,729
Dr Carl Mendel (Senior Vp, R&D (Thru 6/2019))	$314,789	$0	$36,162
Dr Eugene Sun (Senior Vp, R&D (Eff 6/2019)	$232,966	$0	$30,118
Dr Bruce Carter (Chairman)	$0	$0	$0
Dr Mario Raviglione (Vice Chair)	$0	$0	$0
Dr Debrework Zewdie (Vice Chair (Thru 12/2019))	$0	$0	$0
Jan Landberg From 12 (Director)	$0	$0	$0
David Norton (Director (Thru 12/2019))	$0	$0	$0
Ariel Pablos Mendez (Director)	$0	$0	$0
Nancy Miller Rich (Director)	$0	$0	$0
Shalini Sharp (Director)	$0	$0	$0
Mitchell Warren From (Director)	$0	$0	$0

+ View more people

990

Filed on Oct. 27, 2020

Primary tax return for a nonprofit’s activities, finances, and governance

View Filing

Schedules ▼

PDF XML

990-T

For unrelated business income from activities not substantially related to the organization's tax-exempt purpose

PDF

Audit

Audit for an entity that spends $750,000+ in federal grant money in a fiscal year

PDF

Fiscal Year Ending Dec.
2018

Revenue

$63,283,490

Expenses

$60,315,645

Net Income

$2,967,845

Net Assets

$59,409,768

Notable Sources of Revenue		Percent of Total Revenue
Contributions	$62,252,482	98.4%
Program Services	$0
Investment Income	$1,019,722	1.6%
Bond Proceeds	$0
Royalties	$0
Rental Property Income	$0
Net Fundraising	$0
Sales of Assets	$0
Net Inventory Sales	$0
Other Revenue	$11,286	0.0%

Notable Expenses		Percent of Total Expenses
Executive Compensation	$2,913,398	4.8%
Professional Fundraising Fees	$0
Other Salaries and Wages	$8,393,448	13.9%

Assets/Debt
Total Assets	$75,171,538
Total Liabilities	$15,761,770
Net Assets	$59,409,768

Compensation

Key Employees and Officers	Compensation	Related	Other
Dr Melvin Spigelman (President/Ceo)	$782,343	$0	$76,977
Dr Carl Mendel (Senior Vp, R&D)	$483,354	$0	$65,110
Dr Nader Fotouhi (Chief Scientific Officer)	$464,552	$0	$76,297
Colleen Pero (Secretary/Cao)	$385,515	$0	$43,006
Dr Daniel Everitt (Sr. Medical Officer & Vp)	$384,024	$0	$41,966
Robert Lorette (Sr. Vp, Business Development)	$365,751	$0	$55,546
Dr Paul Bruinenberg (Sr. Medical Officer)	$323,004	$0	$53,269
Dr Kathleen Schostack (Vp, Program & Alliance Mgmt.)	$321,092	$0	$64,467
Willo Brock (Senior Vp, External Affairs)	$321,016	$0	$52,072
Dr Angelo Del Parigi (Sr. Medical Officer)	$320,607	$0	$65,901
Angela Vanderploeg (Treasurer/Cfo (From 7/18))	$132,830	$0	$30,326
Dr Bruce Carter (Chairman)	$0	$0	$0
Dr Mario Raviglione (Vice Chair (From 1/18))	$0	$0	$0
Dr Debrework Zewdie (Vice Chair)	$0	$0	$0
Karl Hofmann Thru 123118 (Director)	$0	$0	$0
David Norton (Director)	$0	$0	$0
Ariel Pablos Mendez (Director)	$0	$0	$0
Nancy Miller Rich (Director (From 1/18))	$0	$0	$0
Paul Sekhri (Director)	$0	$0	$0
Shalini Sharp (Director)	$0	$0	$0

+ View more people

990

Filed on Oct. 29, 2019

Primary tax return for a nonprofit’s activities, finances, and governance

View Filing

Schedules ▼

PDF XML

990-T

For unrelated business income from activities not substantially related to the organization's tax-exempt purpose

PDF

Audit

Audit for an entity that spends $750,000+ in federal grant money in a fiscal year

PDF

Fiscal Year Ending Dec.
2017

Revenue

$58,006,498

Expenses

$56,120,604

Net Income

$1,885,894

Net Assets

$56,554,339

Notable Sources of Revenue		Percent of Total Revenue
Contributions	$57,593,669	99.3%
Program Services	$0
Investment Income	$357,901	0.6%
Bond Proceeds	$0
Royalties	$0
Rental Property Income	$0
Net Fundraising	$0
Sales of Assets	$0
Net Inventory Sales	$0
Other Revenue	$54,928	0.1%

Notable Expenses		Percent of Total Expenses
Executive Compensation	$3,037,978	5.4%
Professional Fundraising Fees	$0
Other Salaries and Wages	$7,281,019	13.0%

Assets/Debt
Total Assets	$72,985,406
Total Liabilities	$16,431,067
Net Assets	$56,554,339

Compensation

Key Employees and Officers	Compensation	Related	Other
Dr Melvin Spigelman (President/Ceo)	$755,994	$0	$67,787
Dr Carl Mendel (Senior Vp, R&D)	$469,303	$0	$62,183
Dr Nader Fotouhi (Chief Scientific Officer)	$420,362	$0	$70,437
Dr Daniel Everitt (Sr. Medical Officer & Vp)	$372,367	$0	$41,011
Colleen Pero (Secretary/Cao)	$371,421	$0	$42,508
Robert Lorette (Sr. Vp, Business Development)	$355,152	$0	$52,913
Stephen Jasko Thru 1117 (Treasurer/Cfo)	$354,226	$0	$61,954
Willo Brock (Senior Vp, External Affairs)	$311,917	$0	$49,886
Dr Christopher Cooper (Sr. Director, Chemistry)	$284,454	$0	$60,066
Dr Majda Benhayon (Sr. Dir., Clinical Operations)	$270,727	$0	$59,123
Dr Rajneesh Taneja (Sr. Director, Ppd)	$270,048	$0	$58,713
Dr Bruce Carter (Chairman From 1/17)	$0	$0	$0
Dr Debrework Zewdie (Vice Chair)	$0	$0	$0
Dr Jan Gheuens Thru 617 (Director)	$0	$0	$0
Karl Hofmann (Director)	$0	$0	$0
David Norton (Director)	$0	$0	$0
Paul Sekhri (Director)	$0	$0	$0
Shalini Sharp (Director)	$0	$0	$0

+ View more people

990

Filed on Nov. 1, 2018

Primary tax return for a nonprofit’s activities, finances, and governance

View Filing

Schedules ▼

PDF XML

Audit

Audit for an entity that spends $750,000+ in federal grant money in a fiscal year

PDF

Fiscal Year Ending Dec.
2016

Revenue

$53,033,369

Expenses

$54,033,661

Net Income

-$1,000,292

Net Assets

$54,536,961

Notable Sources of Revenue		Percent of Total Revenue
Contributions	$52,895,919	99.7%
Program Services	$0
Investment Income	$137,450	0.3%
Bond Proceeds	$0
Royalties	$0
Rental Property Income	$0
Net Fundraising	$0
Sales of Assets	$0
Net Inventory Sales	$0
Other Revenue	$0

Notable Expenses		Percent of Total Expenses
Executive Compensation	$1,579,162	2.9%
Professional Fundraising Fees	$0
Other Salaries and Wages	$7,217,400	13.4%

Assets/Debt
Total Assets	$83,056,988
Total Liabilities	$28,520,027
Net Assets	$54,536,961

990

Primary tax return for a nonprofit’s activities, finances, and governance

PDF

Audit

Audit for an entity that spends $750,000+ in federal grant money in a fiscal year

PDF

Fiscal Year Ending Dec.
2015

Revenue

$61,262,524

Expenses

$57,842,666

Net Income

$3,419,858

Net Assets

$55,601,712

Notable Sources of Revenue		Percent of Total Revenue
Contributions	$61,185,278	99.9%
Program Services	$0
Investment Income	$77,246	0.1%
Bond Proceeds	$0
Royalties	$0
Rental Property Income	$0
Net Fundraising	$0
Sales of Assets	$0
Net Inventory Sales	$0
Other Revenue	$0

Notable Expenses		Percent of Total Expenses
Executive Compensation	$1,534,605	2.7%
Professional Fundraising Fees	$0
Other Salaries and Wages	$7,140,189	12.3%

Assets/Debt
Total Assets	$104,991,923
Total Liabilities	$49,390,211
Net Assets	$55,601,712

990

Primary tax return for a nonprofit’s activities, finances, and governance

PDF

Audit

Audit for an entity that spends $750,000+ in federal grant money in a fiscal year

PDF

Fiscal Year Ending Dec.
2014

Revenue

$45,896,921

Expenses

$43,236,701

Net Income

$2,660,220

Net Assets

$52,316,234

Notable Sources of Revenue		Percent of Total Revenue
Contributions	$45,811,586	99.8%
Program Services	$0
Investment Income	$85,335	0.2%
Bond Proceeds	$0
Royalties	$0
Rental Property Income	$0
Net Fundraising	$0
Sales of Assets	$0
Net Inventory Sales	$0
Other Revenue	$0

Notable Expenses		Percent of Total Expenses
Executive Compensation	$1,513,263	3.5%
Professional Fundraising Fees	$0
Other Salaries and Wages	$6,704,412	15.5%

Assets/Debt
Total Assets	$87,024,911
Total Liabilities	$34,708,677
Net Assets	$52,316,234

990

Primary tax return for a nonprofit’s activities, finances, and governance

PDF

Fiscal Year Ending Dec.
2013

Revenue

$46,117,957

Expenses

$40,579,516

Net Income

$5,538,441

Net Assets

$49,924,527

Notable Sources of Revenue		Percent of Total Revenue
Contributions	$46,049,742	99.9%
Program Services	$0
Investment Income	$68,215	0.1%
Bond Proceeds	$0
Royalties	$0
Rental Property Income	$0
Net Fundraising	$0
Sales of Assets	$0
Net Inventory Sales	$0
Other Revenue	$0

Notable Expenses		Percent of Total Expenses
Executive Compensation	$1,463,479	3.6%
Professional Fundraising Fees	$0
Other Salaries and Wages	$6,129,581	15.1%

Assets/Debt
Total Assets	$71,932,038
Total Liabilities	$22,007,511
Net Assets	$49,924,527

990

Primary tax return for a nonprofit’s activities, finances, and governance

PDF

Fiscal Year Ending Dec.
2012

Revenue

$46,256,409

Expenses

$42,645,054

Net Income

$3,611,355

Net Assets

$44,243,935

Notable Sources of Revenue		Percent of Total Revenue
Contributions	$46,145,270	99.8%
Program Services	$0
Investment Income	$111,139	0.2%
Bond Proceeds	$0
Royalties	$0
Rental Property Income	$0
Net Fundraising	$0
Sales of Assets	$0
Net Inventory Sales	$0
Other Revenue	$0

Notable Expenses		Percent of Total Expenses
Executive Compensation	$1,428,004	3.3%
Professional Fundraising Fees	$0
Other Salaries and Wages	$6,258,477	14.7%

Assets/Debt
Total Assets	$58,144,210
Total Liabilities	$13,900,275
Net Assets	$44,243,935

990

Primary tax return for a nonprofit’s activities, finances, and governance

PDF

Fiscal Year Ending Dec.
2011

Revenue

$46,946,367

Expenses

$36,738,555

Net Income

$10,207,812

Net Assets

$40,594,814

Notable Sources of Revenue		Percent of Total Revenue
Contributions	$46,790,804	99.7%
Program Services	$0
Investment Income	$155,563	0.3%
Bond Proceeds	$0
Royalties	$0
Rental Property Income	$0
Net Fundraising	$0
Sales of Assets	$0
Net Inventory Sales	$0
Other Revenue	$0

Notable Expenses		Percent of Total Expenses
Executive Compensation	$1,322,986	3.6%
Professional Fundraising Fees	$0
Other Salaries and Wages	$5,524,984	15.0%

Assets/Debt
Total Assets	$51,559,287
Total Liabilities	$10,964,473
Net Assets	$40,594,814

Nonprofit Explorer has organizations claiming tax exemption in each of the 27 subsections of the 501(c) section of the tax code, and which have filed a Form 990, Form 990EZ or Form 990PF. Taxable trusts and private foundations that are required to file a form 990PF are also included. Small organizations filing a Form 990N "e-Postcard" are not included in this data.

Types of Nonprofits

There are 27 nonprofit designations based on the numbered subsections of section 501(c) of the tax code. See the list »

Get the Data

For those interested in acquiring the original data from the source, here’s where our data comes from:

Raw filing data. Includes EINs and summary financials as structured data.
Exempt Organization profiles. Includes organization names, addresses, etc. You can merge this with the raw filing data using EIN numbers.
Form 990 documents. Prior to 2017, these documents were obtained and processed by Public.Resource.org and ProPublica. Bulk PDF downloads since 2017 are available from the IRS.
Form 990 documents as XML files. Includes complete filing data (financial details, names of officers, tax schedules, etc.) in machine-readable format. Only available for electronically filed documents. Electronic data released prior to October 2021 is also available through Amazon Web Services.
Audits. PDFs of single or program-specific audits for nonprofit organizations that spent $750,000 or more in Federal grant money in a single fiscal year. Available for fiscal year 2015 and later.

API

The data powering this website is available programmatically, via an API. Read the API documentation »

By Andrea Suozzo, Alec Glassford and Ash Ngu, ProPublica, and Brandon Roberts, Special to ProPublica.
Design by Jeff Frankl. Additional development by Ken Schwencke, Mike Tigas, and Sisi Wei.

E-file viewer adapted from IRS e-File Viewer by Ben Getson. Code for scraping audit documents adapated from Govwiki.

Updated December 20, 2024

Global Alliance For Tb Drug Development Inc

Organization summary

Type of Nonprofit

Summary charts: organization finances over time

Revenue $60.2M (2023)

Expenses $55.4M (2023)

Total Assets $197M (2023)

Total Liabilities $25.6M (2023)

Tax Filings and Audits by Year

Fiscal Year Ending Dec. 2023

Extracted Financial Data

Extracted Financial Data from Form 990

Compensation

Document Links

990

Audit

Fiscal Year Ending Dec. 2022

Extracted Financial Data

Extracted Financial Data from Form 990

Compensation

Document Links

990

Audit

Fiscal Year Ending Dec. 2021

Extracted Financial Data

Extracted Financial Data from Form 990

Compensation

Document Links

990

Audit

Fiscal Year Ending Dec. 2020

Extracted Financial Data

Extracted Financial Data from Form 990

Compensation

Document Links

990

Audit

Fiscal Year Ending Dec. 2019

Extracted Financial Data

Extracted Financial Data from Form 990

Compensation

Document Links

990

990-T

Audit

Fiscal Year Ending Dec. 2018

Extracted Financial Data

Extracted Financial Data from Form 990

Compensation

Document Links

990

990-T

Audit

Fiscal Year Ending Dec. 2017

Extracted Financial Data

Extracted Financial Data from Form 990

Compensation

Document Links

990

Audit

Fiscal Year Ending Dec. 2016

Extracted Financial Data

Extracted Financial Data from Form 990

Document Links

990

Audit

Fiscal Year Ending Dec. 2015

Extracted Financial Data

Extracted Financial Data from Form 990

Document Links

990

Audit

Fiscal Year Ending Dec. 2014

Extracted Financial Data

Extracted Financial Data from Form 990

Document Links

990

Fiscal Year Ending Dec. 2013

Extracted Financial Data

Extracted Financial Data from Form 990

Revenue

$60.2M (2023)

Expenses

$55.4M (2023)

Total Assets

$197M (2023)

Total Liabilities

$25.6M (2023)

Fiscal Year Ending Dec.
2023

Fiscal Year Ending Dec.
2022

Fiscal Year Ending Dec.
2021

Fiscal Year Ending Dec.
2020

Fiscal Year Ending Dec.
2019

Fiscal Year Ending Dec.
2018

Fiscal Year Ending Dec.
2017

Fiscal Year Ending Dec.
2016

Fiscal Year Ending Dec.
2015

Fiscal Year Ending Dec.
2014

Fiscal Year Ending Dec.
2013

Fiscal Year Ending Dec.
2012

Fiscal Year Ending Dec.
2011

Fiscal Year Ending Dec.
2010

Fiscal Year Ending Dec.
2009

Fiscal Year Ending Dec.
2008

Fiscal Year Ending Dec.
2007

Fiscal Year Ending Dec.
2006

Fiscal Year Ending Dec.
2005

Fiscal Year Ending Dec.
2004

Fiscal Year Ending Dec.
2003

Fiscal Year Ending Dec.
2002

Fiscal Year Ending Dec.
2001

Fiscal Year Ending Dec.
2000